LoginRegister
    Morocco to roll out antimalarials against coronavirusMorocco to roll out antimalarials against coronavirus
    Eli Lilly delays its clinical trials during Coronavirus pandemicEli Lilly delays its clinical trials during Coronavirus pandemic
    Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animalsPharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals
    Government appeals to various industry bodies, manufacturers to streamline supply of Body Coveralls, N-95 Masks, other PPE for healthcare workersGovernment appeals to various industry bodies, manufacturers to streamline supply of Body Coveralls,...
    Invest India Business Immunity Platform launched to helping businesses withstand COVID-19Invest India Business Immunity Platform launched to helping businesses withstand COVID-19
    Immediate prohibition on export of all ventilators, artificial respiratory apparatus, oxygen therapy apparatus, breathing device as well as sanitizersImmediate prohibition on export of all ventilators, artificial respiratory apparatus, oxygen therapy...
    Bayer and Curadev sign research collaboration and license agreement for STING antagonistsBayer and Curadev sign research collaboration and license agreement for STING antagonists
    Mylab gets DCGI commercial approval for COVID-19 test kitMylab gets DCGI commercial approval for COVID-19 test kit
    Glenmark divests VWash, a female intimate hygiene wash, to Hindustan UnileverGlenmark divests VWash, a female intimate hygiene wash, to Hindustan Unilever
    Gilead puts emergency access to experimental coronavirus drug on hold amid surging demandGilead puts emergency access to experimental coronavirus drug on hold amid surging demand
    CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19
    AstraZeneca gets orphan drug designation for pancreatic cancer drug LynparzaAstraZeneca gets orphan drug designation for pancreatic cancer drug Lynparza
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X